| Patents for A61K 38 - Medicinal preparations containing peptides (316,240) |
|---|
| 02/19/2003 | EP1284140A2 Use of ritonavir (ABT-538) for improving the pharmacokinetics of drugs metabolized by cytochrome P450 in a method of treating aids |
| 02/19/2003 | EP1284137A1 Nonoral preparation having three-layer structure |
| 02/19/2003 | EP1283889A1 Mutated eukariotic translation initiation factor 2 alpha kinase 3, eif2ak3, in patients with neonatal insulin-dependent diabetes and multiple epiphyseal dysplasia (wolcott-rallison syndrome) |
| 02/19/2003 | EP1283886A2 Intracellular signaling proteins |
| 02/19/2003 | EP1283885A2 Compositions and methods for the therapy and diagnosis of breast cancer |
| 02/19/2003 | EP1283883A1 Treatment of cancer and neurological diseases |
| 02/19/2003 | EP1283882A1 Ssa-56kda polypeptide and its fragments and polynucleotides encoding said polypeptides and therapeutic uses |
| 02/19/2003 | EP1283879A2 Molecules that modulate ubiquitin-dependent proteolysis and methods for identifying same |
| 02/19/2003 | EP1283874A2 Novel deoxynucleoside kinase enzyme variants |
| 02/19/2003 | EP1283871A2 Production of dendritic cells from bone-marrow stem cells |
| 02/19/2003 | EP1283869A2 Novel bee venom polypeptides and methods of use thereof |
| 02/19/2003 | EP1283851A2 Use of interleukin-4 antagonists and compositions thereof |
| 02/19/2003 | EP1283850A2 Thrombospondin type 1 repeat polypeptides |
| 02/19/2003 | EP1283849A2 Human receptor proteins; related reagents and methods |
| 02/19/2003 | EP1283848A2 Protein complexes and assays for screening anti-cancer agents |
| 02/19/2003 | EP1283735A2 Method for the improvement of islet signaling in diabetes mellitus and for its prevention |
| 02/19/2003 | EP1283726A2 Dendritic cells loaded with toxic substances |
| 02/19/2003 | EP1283722A1 Combined use of anti-cytokine antibodies or antagonists and anti-cd20 for the treatment of b cell lymphoma |
| 02/19/2003 | EP1283715A1 Modulaton of alpha-6 integrin-mediated responses |
| 02/19/2003 | EP1283700A2 Sustained release pharmaceutical compositions for parenteral administration of hydrophilic compounds |
| 02/19/2003 | EP1283682A2 Tryptophan source from plants and uses therefor |
| 02/19/2003 | EP1283675A1 Methods of modulating the activity of mura |
| 02/19/2003 | EP1133314B1 Protein c for the treatment of sickle cell disease and thalassemia |
| 02/19/2003 | EP1081159B1 Purified human activin and process for producing the same |
| 02/19/2003 | EP1056777A4 Ligand receptors and uses therefor |
| 02/19/2003 | EP1020179A4 Peptide derivatives or pharmaceutically acceptable salts thereof, method for producing the same, use of said derivatives and pharmaceutical composition |
| 02/19/2003 | EP0950065B1 Peptide as diagnostic and therapeutic agent for autoimmune diseases |
| 02/19/2003 | EP0818996B1 Controlled release biodegradable micro- and nanospheres containing cyclosporin |
| 02/19/2003 | EP0777485B1 2',5' phosphorothioate/phosphodiester oligoadenylates and antiviral uses thereof |
| 02/19/2003 | EP0483304B1 Method of inactivation of viral and bacterial blood contaminants |
| 02/19/2003 | CN1398298A Non-endogenous, constitutively activated human G protein-coupled receptors |
| 02/19/2003 | CN1398297A Recombinant flaviviruses and methods of use thereof |
| 02/19/2003 | CN1398189A Combination therapy of radiation and COX-2 inhibitor for treatment of neoplasia |
| 02/19/2003 | CN1398188A Boltuminum toxin pharmaceutical compsns |
| 02/19/2003 | CN1398187A Method and compsns. for treating liver cell cancer |
| 02/19/2003 | CN1398183A Medicament contg. platinum complex compounds and use thereof |
| 02/19/2003 | CN1397641A Virus reproduced in tumor cell for expressing angiogenesis suppressor factor and its configuring process |
| 02/19/2003 | CN1397345A Ouabain conjugated peptide or protein and its application in treating hypertension |
| 02/19/2003 | CN1397344A Compound steam cell medicine, its preparing process and its application |
| 02/19/2003 | CN1101823C Shark liver irritant for preventing and treating hepatism and its prepn. process |
| 02/19/2003 | CN1101703C Liquid medicine for radically treating wart |
| 02/19/2003 | CN1101702C Compound capsules contg. granulocyte colony stimulating factor and polyose |
| 02/19/2003 | CN1101701C composn. for nasal administration of desmopressin, its prepn. process and use |
| 02/19/2003 | CN1101700C Polypeptide oral liquor |
| 02/19/2003 | CN1101695C Application of medicine from plant extracts for treatment of increase bone resorption, and compsns, thereof |
| 02/19/2003 | CA2463490A1 Therapeutic polypeptides, nucleic acids encoding same, and methods of use |
| 02/19/2003 | CA2420065A1 Methods for indentifying specifically cleavable peptides and use of such peptide sequences |
| 02/18/2003 | US6521750 Nucleotide sequence coding human protein for use in treatment of osteoporosis and bone disorders |
| 02/18/2003 | US6521749 GL50 nucleic acids and uses therefor |
| 02/18/2003 | US6521741 Catalytic antibodies and a method of producing same |
| 02/18/2003 | US6521740 Expression vectors; genetic engineering |
| 02/18/2003 | US6521739 Complete genome sequence of a simian immunodeficiency virus from a red-capped mangabey |
| 02/18/2003 | US6521654 Substituted imidazolidine derivatives, their preparation, their use and pharmaceutical preparations including them |
| 02/18/2003 | US6521647 Treatment of renal disorders |
| 02/18/2003 | US6521645 Methods for the treatment and prevention of urinary stone disease |
| 02/18/2003 | US6521633 Treating NIDDM with RXR agonists |
| 02/18/2003 | US6521612 Antibiotic compounds |
| 02/18/2003 | US6521602 Anti-neoplastic compositions and uses thereof |
| 02/18/2003 | US6521599 Carrier comprises glycine and aqueous hydrochloric acid; compatability; neutralization |
| 02/18/2003 | US6521598 Peptide consisting of an amino acid sequence 1: SPSVDKARAEL; induces transplant tolerance |
| 02/18/2003 | US6521597 Water soluble polysaccharide mixed with luteinizing hormone releasing hormone analogues; bioavailability; chemically stability; longer useful shelf life |
| 02/18/2003 | US6521594 Method and composition for treating thrombosis |
| 02/18/2003 | US6521593 Using antagonists of integrins such as alpha v beta 3 and alpha v beta 5; inhibiting angiogenesis and vitronectin and tenascin mediated cell adhesion; inducing apoptosis |
| 02/18/2003 | US6521590 Amino acid sequence containing cysteine/glycine domain of chitin binding plant proteins; better activity against pathogenic fungi; transgenic plants expressing the protein show increased disease resistance |
| 02/18/2003 | US6521450 Cells expressing a modified regulator of complement activation |
| 02/18/2003 | US6521448 Porcine MHC class I genes and uses thereof |
| 02/18/2003 | US6521441 Staphylococcus aureus genes and polypeptides |
| 02/18/2003 | US6521439 Nucleic acids encoding plasminogen fragments |
| 02/18/2003 | US6521437 Human sphingosine lyase polypeptides |
| 02/18/2003 | US6521436 Gene expression; drug screening for antiarthritic agents; bone disorders |
| 02/18/2003 | US6521434 Nucleotide sequences coding enzymatic polypeptide; for use as a bactericide |
| 02/18/2003 | US6521432 Methods for enhancing the rate of modification of metastable bonds |
| 02/18/2003 | US6521424 Recombinant expression of Tek antagonists |
| 02/18/2003 | US6521422 Fhm, a novel member of the TNF ligand supergene family |
| 02/18/2003 | US6521420 Gene expression; diagnosing high blood pressure |
| 02/18/2003 | US6521418 G protein-coupled receptor with an enlarged extracellular domain |
| 02/18/2003 | US6521417 Incubating permeabilized cells expressing mutant kinase with radiolabeled analog; cytolysis, separation by sodium dodecyl sulfate polyacrylamide gel electrophoresis |
| 02/18/2003 | US6521415 Tandem immuno-assay for cancer |
| 02/18/2003 | US6521413 Bioassay; monitoring cells for changes in ion channel activity |
| 02/18/2003 | US6521412 Drug screening for anticarcinogenic agents and agents to treat atherosclerosis and neurodegenerative disorders |
| 02/18/2003 | US6521253 Low molecular weight peptide thrombin inhibitor having pH dependent solubility and a combination of microcrystalline cellulose and sodium starch glycollate |
| 02/18/2003 | US6521245 Treatment with recombinant human erythropoietin of bleeding in patients with normal and abnormal hemostasis |
| 02/18/2003 | US6521244 Body filling material |
| 02/18/2003 | US6521242 Method for sequestration of nasal secretion skin irritants with facial tissue |
| 02/18/2003 | US6521241 That can bind a cytokine; clay, silica, titanium dioxide, and combinations thereof |
| 02/18/2003 | US6521240 That can bind a cytokine; clay, silica, titanium dioxide, and combinations thereof |
| 02/18/2003 | US6521233 DNA sequence codes for polypeptides having collagen domain peptide amino acid sequences capable of dimerization or oligomerization; fusion proteins |
| 02/18/2003 | US6521232 Proteins having immunomodulatory activity and remedies for immunological diseases |
| 02/18/2003 | US6521230 CD25 binding molecules |
| 02/18/2003 | US6521229 41 kDa Cryptosporidium parvum oocyst wall protein |
| 02/18/2003 | US6521226 Administering Paraoxonase-1 (PON-1), an expressed protein that has hydrolase activity for organophosphates, and antioxidation activity for low-density lipoprotein (LDL) |
| 02/18/2003 | CA2283450C Methods for treatment of scar tissue |
| 02/18/2003 | CA2130072C Method of detecting a pathogen using a virus |
| 02/18/2003 | CA2085750C Osteoinductive pharmaceutical formulations |
| 02/18/2003 | CA2067031C Dna coding for human cell surface antigen |
| 02/18/2003 | CA2064331C Vascular endothelial cell growth factor c subunit |
| 02/17/2003 | CA2356390A1 Synthetic peptide of regulatory virus protein r (vpr) of human immunodeficiency virus type 1 (hiv-1) and the utilization thereof |
| 02/15/2003 | CA2392305A1 Adrenic acid receptor and uses thereof |
| 02/13/2003 | WO2003012441A1 Method for detecting modulators of notch signalling |
| 02/13/2003 | WO2003012432A1 Erythropoietin and anti-tumor necrosis factor alpha combination therapy |